2-pyrrolidin-1-yl-7-(2-thienyl)[1,3]thiazolo[4,5-d]pyridazin-4(5H)-one, 95.0%, 250mg

2,3,5-Trichlorophenylboronic Acid (contains varying amounts of Anhydride)>98.0%(HPLC)(T)1g

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate, 95.0%, 1g

2-Fluoro-3-(trifluoromethyl)pyridine, 98.0%, 100g

2,3,6,7-Tetrachloroquinoxaline, 95.0%, 250mg

(R)-1-(p-Tolyl)ethan-1-ol, 95.0%, 10g

3-(2,4-Difluorophenyl)-3-oxo-propionic acid methyl ester, 95.0%, 5g

pUC19-Marker ready-to-use, 2 ml, 4 x 0,5 ml

H-Thr(tBu)-OMe.HCl, 95+%, 1g

2-((4-Chloropyridin-2-yl)oxy)acetic acid, 95%, 500mg

2-Fluoro-6-iodobenzaldehyde, 97.0%, 5g

(R)-1-CYCLOPROPYLETHANAMINE HCL, 95.0%, 5g

(S)-3-METHYL-2-(1-OXOISOINDOLIN-2-YL)BUTANOIC ACID, 95.0%, 500mg